MedTrace Logo

Vaginal Progesterone Supplementation in the Management of Preterm Labor

NCT03202836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2019-01-31

No results posted yet for this study

Summary

This study evaluates the addition of vaginal progesterone in the management of preterm labor. Half of participants will receive vaginal progesterone, tocolysis and corticosteroid, while the other half will receive only tocolysis and corticosteroid.

Conditions

  • Preterm Labor

Interventions

DRUG

progesterone

vaginal utrogestan

DRUG

Tocolytics

tocolysis for 48 hours

DRUG

Steroids

antenatal corticosteroids for 48 hours

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Vorapong Phupong, MD · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-29
Primary Completion
2018-07-30
Completion
2018-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03202836 on ClinicalTrials.gov